In patients with type 2 diabetes, the damage to the erythropoietin‐producing cells of the proximal tubule may be even more pronounced39 due to the greater extent of ATP production (and greater amount of oxygen consumption/hypoxia) that accompanies elevated SGLT‐2 activity. Here, EPO is linked to type 2 diabetes mellitus.